Profile data is unavailable for this security.
About the company
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
- Revenue in USD (TTM)31.75m
- Net income in USD-473.56k
- Incorporated1989
- Employees82.00
- LocationCryo-Cell International Inc700 BROOKER CREEK BLVD, SUITE 1800OLDSMAR 34677United StatesUSA
- Phone+1 (813) 749-2104
- Fax+1 (813) 855-4745
- Websitehttps://www.cryo-cell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Medical Services Hldgs Ltd (ADR) | 52.95m | -23.61m | 16.41m | 595.00 | -- | -- | -- | 0.31 | -5.41 | -5.41 | 12.12 | -74.67 | 0.0548 | 15.23 | 5.40 | 88,987.31 | -7.92 | -9.88 | -149.26 | -52.45 | -11.44 | -16.74 | -144.56 | -136.95 | 0.4122 | -17.31 | 0.679 | -- | -28.55 | 14.12 | -3.56 | -- | -7.16 | -- |
| Healthlynked Corp | 2.37m | -3.83m | 16.48m | 20.00 | -- | -- | -- | 6.94 | -1.36 | -1.36 | 0.8411 | -1.91 | 1.05 | 20.87 | 1.51 | 118,702.50 | -169.54 | -114.35 | -- | -274.57 | 51.29 | 54.88 | -161.50 | -125.90 | 0.224 | -1.33 | -- | -- | -47.43 | -5.63 | -69.66 | -- | -23.71 | -- |
| Pacific Health Care Organization Inc | 6.67m | 1.45m | 16.90m | 29.00 | 11.68 | 1.32 | 11.46 | 2.53 | 0.113 | 0.113 | 0.5207 | 1.00 | 0.5248 | -- | 6.32 | 230,114.80 | 11.39 | 6.41 | 11.95 | 6.87 | 81.60 | 81.57 | 21.70 | 12.77 | -- | -- | 0.00 | -- | 7.73 | -3.72 | 15.06 | -5.91 | -31.19 | -- |
| Longduoduo Co Ltd | 2.72m | -295.40k | 17.81m | 52.00 | -- | 20.23 | -- | 6.54 | -0.0099 | -0.0099 | 0.0907 | 0.0293 | 1.27 | -- | 52.80 | 52,348.65 | -15.59 | -105.77 | -33.31 | -- | 98.46 | 89.77 | -12.32 | -31.72 | -- | -- | 0.00 | -- | -42.32 | -- | -63.32 | -- | -- | -- |
| Jun An Kang Group Inc | 4.47m | -3.25m | 23.18m | 0.00 | -- | -- | -- | 5.18 | -1,128.15 | -1,128.15 | 24.83 | -3.45 | 1.25 | -- | 8.10 | -- | -91.08 | -- | -654.07 | -- | 49.14 | -- | -72.75 | -- | -- | -1.82 | 2.94 | -- | 39.82 | -- | -15.35 | -- | -- | -- |
| Cryo-Cell International Inc | 31.75m | -473.56k | 27.61m | 82.00 | -- | -- | 53.33 | 0.8695 | -0.0597 | -0.0597 | 3.91 | -1.84 | 0.5035 | 10.50 | 4.63 | 387,164.60 | -0.7511 | -0.2232 | -1.05 | -0.3362 | 77.07 | 71.48 | -1.49 | -0.4164 | 0.5971 | 1.48 | -- | -- | 2.05 | 0.1064 | 104.22 | -29.39 | 29.41 | -- |
| Elite Health Systems Inc | 0.00 | -3.05m | 29.62m | 3.00 | -- | 5.90 | -- | -- | -0.1377 | -0.1377 | 0.00 | 0.2288 | 0.00 | -- | -- | 0.00 | -66.86 | -31.33 | -69.63 | -40.26 | -- | -- | -- | -115.33 | -- | -4.91 | 0.00 | -- | -- | -- | -151.84 | -- | -- | -- |
| Cardiff Lexington Corp | 11.88m | -4.74m | 29.93m | 13.00 | -- | -- | -- | 2.52 | -0.8178 | -0.8178 | 2.07 | 0.7556 | 0.4649 | -- | 0.6696 | 914,156.10 | -14.60 | -9.53 | -52.92 | -88.21 | 62.83 | 61.72 | -31.40 | -14.84 | -- | 0.3669 | 0.751 | -- | -30.23 | 12.74 | -277.91 | -- | -- | -- |
| rYojbaba Co Ltd | 11.52m | 1.38m | 31.28m | 139.00 | 22.67 | 9.74 | 17.83 | 2.71 | 0.1226 | 0.1226 | 1.02 | 0.2854 | 0.7445 | 90.49 | 7.66 | 82,902.73 | 8.91 | -- | 11.84 | -- | 38.39 | -- | 11.97 | -- | 1.83 | 27.27 | 0.6054 | -- | 5.60 | -- | 72.91 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| SFI Advisors LLCas of 31 Dec 2025 | 165.30k | 2.05% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 127.65k | 1.59% |
| MML Investors Services LLCas of 31 Dec 2025 | 111.04k | 1.38% |
| Geode Capital Management LLCas of 31 Dec 2025 | 53.17k | 0.66% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 23.35k | 0.29% |
| Northern Trust Global Investments Ltd.as of 30 Sep 2025 | 23.26k | 0.29% |
| Cerity Partners LLCas of 31 Dec 2025 | 19.56k | 0.24% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 11.81k | 0.15% |
| Citadel Securities LLCas of 30 Sep 2025 | 11.40k | 0.14% |
| G1 Execution Services LLCas of 30 Sep 2025 | 11.06k | 0.14% |
